Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diarrhea | 2 | 2012 | 73 | 0.440 |
Why?
|
| Adenomatous Polyps | 1 | 2012 | 1 | 0.380 |
Why?
|
| Ileal Diseases | 1 | 2012 | 6 | 0.380 |
Why?
|
| Ileum | 1 | 2012 | 21 | 0.380 |
Why?
|
| Intussusception | 1 | 2012 | 16 | 0.370 |
Why?
|
| Crohn Disease | 2 | 2014 | 107 | 0.370 |
Why?
|
| Colon | 1 | 2012 | 147 | 0.340 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2010 | 9 | 0.330 |
Why?
|
| Pouchitis | 1 | 2010 | 8 | 0.330 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 77 | 0.310 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 166 | 0.270 |
Why?
|
| Feces | 3 | 2014 | 118 | 0.270 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2009 | 183 | 0.270 |
Why?
|
| Gastrointestinal Diseases | 2 | 2017 | 71 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 875 | 0.220 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 991 | 0.150 |
Why?
|
| Angelman Syndrome | 1 | 2017 | 5 | 0.130 |
Why?
|
| Adolescent | 5 | 2017 | 6305 | 0.120 |
Why?
|
| Trisomy | 1 | 2015 | 22 | 0.110 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 27 | 0.090 |
Why?
|
| Factitious Disorders | 1 | 2012 | 2 | 0.090 |
Why?
|
| Failure to Thrive | 1 | 2012 | 7 | 0.090 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2012 | 4 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2012 | 20 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2012 | 65 | 0.090 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 26 | 0.090 |
Why?
|
| Child | 4 | 2017 | 4612 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 32 | 0.090 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 37 | 0.090 |
Why?
|
| Microbiota | 1 | 2014 | 168 | 0.090 |
Why?
|
| Physical Examination | 1 | 2012 | 109 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 102 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 88 | 0.090 |
Why?
|
| Appendicitis | 1 | 2012 | 84 | 0.090 |
Why?
|
| Anemia | 1 | 2012 | 132 | 0.080 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 126 | 0.080 |
Why?
|
| Fusobacteria | 1 | 2010 | 3 | 0.080 |
Why?
|
| Proteobacteria | 1 | 2010 | 7 | 0.080 |
Why?
|
| Actinobacteria | 1 | 2010 | 8 | 0.080 |
Why?
|
| Bacteroides | 1 | 2010 | 10 | 0.080 |
Why?
|
| Metagenome | 1 | 2010 | 18 | 0.080 |
Why?
|
| Acute Disease | 1 | 2012 | 663 | 0.080 |
Why?
|
| Adalimumab | 1 | 2009 | 30 | 0.080 |
Why?
|
| Infliximab | 1 | 2009 | 50 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 261 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2012 | 742 | 0.070 |
Why?
|
| Biopsy | 1 | 2010 | 456 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 189 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2014 | 820 | 0.070 |
Why?
|
| Young Adult | 3 | 2017 | 4810 | 0.070 |
Why?
|
| Humans | 7 | 2017 | 65121 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2009 | 250 | 0.060 |
Why?
|
| Male | 5 | 2017 | 31039 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1656 | 0.050 |
Why?
|
| Female | 5 | 2017 | 34013 | 0.050 |
Why?
|
| Obesity | 1 | 2012 | 1273 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1322 | 0.050 |
Why?
|
| Infant | 2 | 2017 | 1693 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2017 | 2061 | 0.040 |
Why?
|
| Adult | 2 | 2017 | 17356 | 0.030 |
Why?
|
| Senna Extract | 1 | 2015 | 2 | 0.030 |
Why?
|
| Bisacodyl | 1 | 2015 | 2 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2015 | 3 | 0.030 |
Why?
|
| Enema | 1 | 2015 | 14 | 0.030 |
Why?
|
| Constipation | 1 | 2015 | 15 | 0.030 |
Why?
|
| Superoxides | 1 | 2014 | 73 | 0.030 |
Why?
|
| Metabolomics | 1 | 2014 | 62 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6862 | 0.030 |
Why?
|
| Reference Values | 1 | 2014 | 327 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 173 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 602 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 1445 | 0.020 |
Why?
|
| Middle Aged | 1 | 2010 | 18264 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 1785 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 587 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 410 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 2145 | 0.020 |
Why?
|
| Neutrophils | 1 | 2014 | 390 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1141 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2188 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 1037 | 0.020 |
Why?
|